Clostridium difficile infection and fecal bacteriotherapy

Gastroenterology Nursing

Volumn 36, Issue 1, 2013, Pages 42-50

  Mitchell, Indya ^a   Shropshire, Kasheena ^a   Ruel, Jennifer ^a  

^a UNIVERSITY OF DETROIT MERCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM; CASE REPORT; CLOSTRIDIUM DIFFICILE; FEMALE; HUMAN; INTESTINE; MICROBIOLOGY; PSEUDOMEMBRANOUS COLITIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; PEPTOCLOSTRIDIUM DIFFICILE;

ADULT; BACTERIA; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INTESTINES;

EID: 84873362766     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e318280f817     Document Type: Article

References (13)

1. APRN Joint Dialogue Report. (2008, July). Consensus model for APRN regulation: Lincensure, accreditation, certifi ca-tion & education. Retrieved from http://www.aacn.nche.edu/education-resources/APRNReport.pdf
2. Armitage, C. J. (2008). A volitional hel p sheet to encour-age smoking cessation: A randomized exploratory trial. Health Psychology, 27(5), 557-566. doi:10.1037/0278-6133.27.5.557
3. Bakken, J. S. (2009). Fecal bacteriotherapy for recurrent Clostridium diffi cile infection. Anaerobe, 15, 285-289.
4. Brandt, L. J., Borody, T. J., & Campbell, J. (2011). Endo-scopic fecal microbiota transplantation: "First-line" treatment for severe Clostridium diffi cile infection? [Editorial]. Journal of Clinical Gastroenterology, 45(8), 655-657.
5. Cocanour, C. S. (2011). Best strategies in recurrent or per-sistent clostridium diffi cile infection. Surgical Infections, 12(3), 235-239. doi: 10.1089/sur.2010.080
6. Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V., McDonald, L. C., Infectious Disease Society of America. (2010). Clinical practice guidelines for Clostrid-ium diffi cile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA). Chicago Journals, 31(5), 431-455.
7. Drekonja, D. M., Butler, M., MacDonald, R., Bliss, D., Filice, G. A., Rector, T. S., & Wilt, T. J. (2011). Comparative ef-fectiveness of Clostridium diffi cile treatments. Annals of Internal M edicine, 155(12), 839-847.
8. Garborg, K., Waagsbo, B., Stallemo, A., Matre, J., & Sundoy, A. (2010). Results of faecal donor instillation therapy for recurrent Clostridium diffi cile-associated diarrhea. Scan-dinavian Journal of Infectious Diseases, 42, 857-861.
9. Grant, E. M. (2011). Fidaxomicin: New therapy for Clostrid-ium diffi cile-associated diarrhea. Formulary Journal, 46, 297-308.
10. Johnson, S. (2009). Recurrent Clostridium diffi cile infec-tion: A review of risk factors, treatments, and outcomes. Journal of Infection, 58(6), 403-410. doi:10.1016/j. jinf.2009.03.010
11. McPhee, S. J., & Papadakis, M. (Eds.). (2011). Current medi-cal diagnosis and treatment (50th ed.). New York, NY: McGraw Hill. ISBN: 978-0-07-162444-2
12. Society for Healthcare Epidemiology of America & Infec-tious Diseases Society of America. (2010). Clinical prac-tice guidelines for Clostridium diffi cile infection in adults: 2010 update by Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Retrieved from http://www.jstor.org/ stable/10.1086/651706
13. Vaishnavi, C. (2009). Established and potential risk factors for Clostridium diffi cile infection. Indian Journal of Med-ical Microbiology, 27(4), 289-300.